The field of Genetics is poised to become the cornerstone of medicine as we know it. In the decade to come we will witness a startling transformation in the way we manage diseases and their therapies. Much of this transformation will account due to ground breaking advances in clinical and human genetics happening today. This has opened the doors to new business opportunities that lie completely untapped and unseen. One such opportunity is Genetic Diagnosis.
Lilac Insights is widely regarded as the pioneer in the field of Reproductive Genetics & Cancer Genetics in India. From introducing Prenatal genetic screening and diagnosis to cutting edge cancer genetics program, Lilac Insights has always been ahead of the curve.
We were among the 1st few companies to follow the guidelines and protocols set by internationally renowned organization like Fetal Medicine Foundation (UK) & National Health Service (UK) in India and successfully shape the genetic screening and diagnostics industry of the country.
In the field of Reproductive Genetics, Lilac Insights deals with genetic disorders in a threefold process:
Lilac Insights has developed high-end Cancer Genetic testing panels in the disease areas of
In the year 2019, we started focussing more on Clinical Genetics and its impact on human health. The same year we started the first of its kind clinical and metabolic genetics facility-The Sujanan Clinic at Pune with an aim to help in achieving Good Birth, Good Life. The program is headed by Dr. Chaitanya Datar, who is a Clinical and Metabolic Geneticist. He is ably supported by a team of Clinical Geneticist, Metabolic Dietitian and BGCI certified Genetic Counsellors backed by a state-of-the-art diagnostic facility. It is India’s only private company run program to have such a comprehensive team helping clinicians and patients to get complete care from diagnosis to management. The program deals with Metabolic Genetics, Newborn Screening (NBS), Fetal Autopsy, and Genetic Counseling & Consultation.
Our genetic test reports help for the appropriate prognostication of the disease thereby, help to choose the appropriate treatment confidently on standard chemotherapy, targeted therapy, immunotherapy or palliative care.
At Lilac Insights, we are also looking to expand our services and provide the benefits of growing Genomic tests to the clinicians and patients. We will be soon introducing new genomic tests in different therapeutic segments to provide advanced and accurate diagnostic solutions.